Purpose: This pilot study was done to determine the feasibility and accuracy of University of Florida/National Cancer Institute (UF/NCI) phantoms and Monte Carlo (MC) retrospective dosimetry and had two aims: (1) to determine the anatomic accuracy of UF/NCI phantoms by comparing 3D organ doses in National Wilms Tumor Study (NWTS) patient-matched UF/NCI phantoms to organ doses in corresponding patient-matched CT scans and (2) to compare infield and out-of-field organ dosimetry using two dosimetry methods-standard radiation therapy (RT) treatment planning systems (TPS) and MC dosimetry in these two anatomic models.
INTRODUCTION
The National Wilms Tumor Study (NWTS) conducted five clinical trials that accrued 9236 Wilms tumor (WT) patients during 1969 to 2002. [1] [2] [3] [4] [5] [6] [7] In the earlier NWTS protocols, radiation therapy (RT) fields were designed using two-dimensional (2D) methods, and later in the era of 3D dose planning, investigators were given the option of using either 2D or 3D treatment planning as most fields were anteroposterior (AP-PA) fields to the whole lung, flank, or whole abdomen. For RT quality assurance (QA) review of patients enrolled on NWTS protocols, RT records including paper diagrams of RT portals indicating field extent with respect to skeletal anatomy and X-ray simulator and RT portal films from a sample of patients were reviewed by study investigators. The NWTS did not have the capability of digital data acquisition and storage and thus there was no information available on 3D organ dosimetry. Thus, for the NWTS Late-Effects Study (LES), RT correlation with specific late effects was analyzed by using prescribed doses to standard WT RT fields rather than by 3D organ dosimetry.
Computational human phantoms, such as the University of Florida and National Cancer Institute Phantoms (UF/NCI), represent the newest generation of computational surrogates of patient anatomy that permit preservation of anatomic realism and anthropometric modeling that was not previously available. 8, 9 The UF/NCI library contains 158 pediatric phantoms with heights ranging from 85 to 185 cm (10 cm increments) and weights ranging from 10 to 125 kg (5 kg increments). All phantoms are available in Digital Imaging and Communications in Medicine (DICOM) format with precontoured organs that can be readily used for treatment planning and dosimetry. This computational human phantom series is freely available for research purpose (please contact Dr. Choonsik Lee (choonsik.lee@nih.gov). 10 Many reports have shown that Monte Carlo (MC) dosimetry is more accurate than standard treatment planning system (TPS) dosimetry, especially for out-of-field organs and heterogeneous regions. [11] [12] [13] [14] [15] [16] This pilot study was done to determine the feasibility and accuracy of UF/NCI phantoms and MC retrospective dosimetry and had two aims:
(1) to determine the anatomic accuracy of UF/NCI phantoms by comparing 3D organ doses in NWTS patient-matched UF/NCI phantoms to organ doses in corresponding patient-matched CT scans and (2) to compare infield and out-of-field organ dosimetry using two dosimetry methods-standard RT TPS and MC dosimetry in these two anatomic models.
MATERIALS AND METHODS
A representative sample of 20 NWTS patients, 10 boys and 10 girls, was selected from the NWTS database (Data and Statistical Center, Seattle WA). Their mean age was 50.5 months (15-88 months), mean height was 103.65 cm (81-129 cm) and mean weight was 16.7 kg (9-21 kg). As the original CT scans of these patients were not available, we obtained patient-matched (by height, weight, and sex) DICOM files of CT scans from the imaging archive of the Quality Assurance Review Center, Lincoln RI and UF/NCI Phantoms from the phantom library (Dr. Choonsik Lee). These NWTS patients received the following RT fields: flank (2 patients), whole abdomen (WA) (6 patients), whole lungs (1 patient), and combination of fields (11 patients) . The RT doses were as follows: flank (10-30 Gy), WA (10-40 Gy), and whole lung (12) (13) (14) (15) (Tables 1 and 2 ). These patient-matched CT scans and Phantom DICOM files were imported into the Pinnacle RT TPS v9.10 at Northwestern University. The NWTS patient-specific RT fields (WA, flank, whole lung, or a combination) and RT doses (10-45 Gy) were reconstructed using TPS for these 20 patients in both patient-matched CT and phantoms. The RT field reconstruction and TPS dose planning was supervised by an experienced radiation oncologist (J.A.K.) and senior physicist (M.G.K.) based on review of patient records from the NWTS. The normal organ contours (heart, thyroid gland, kidney, testes, ovaries, and uterus) on the 20 CT scans and phantoms were reviewed by a pediatric radiologist (C.R.). Although there was good anatomic correlation for all other organs, the position of the ovaries was inaccurate in the phantoms. Thus, the ovaries were recontoured based on published MRI-based guidelines. 17 For aim 1, evaluating the anatomic accuracy of the phantoms, the mean TPS doses of the heart, kidney, thyroid gland, testes, and ovaries were obtained for all patient-matched CT scans and phantoms. The percentage of (%) heart volume receiving ≥5 Gy (threshold dose for cardiac mortality in the French study) was also determined. 18 For aim 2, comparing TPS and MC dosimetry, the DICOM files of both CT scan and phantom anatomic models with RT planning and dosimetry data (TPS) were sent to the NCI for MC radiation transport simulation to provide more accurate out-of-field doses. The MC calculations were performed using the X-ray Voxel Monte Carlo (XVMC) code (C.L., M.M., and J.W.J.). 19, 20 The methodology for converting the DICOM data into an input file for the XVMC simulation was described in a previous publication by Lee et al. 10 Extensive benchmarking of the XVMC dosimetry method was performed by comparing against ion chamber measurements in a water phantom for different field sizes and depths as described in a recent publication by Mille et al. 21 All simulations were run on NCI Biowulf high-performance Linux computing cluster, which has 95,000+ cores.
Statistical analysis was performed using Wilcoxon rank-sum test (comparison of two anatomic models-UF/NCI phantoms vs. CT scans) and signed rank test (comparison of two dosimetric methods-TPS vs.
MC dosimetry). These data were summarized by means and ranges, and analyses were conducted in SAS v9.4. Tables 1 and 2 show the mean TPS and MC doses of the heart, kidney, thyroid gland, testes, ovary, and the percentage of heart receiving ≥5 Gy for 10 male and 10 female NWTS patient-matched phantoms and CT scans (columns in Tables 1 and 2 ; aim 1; Figures 1 and 2 ). The NWTS protocol RT fields and doses for these patients are also shown.
RESULTS

Comparison of organ dosimetry in NWTS patient-matched phantoms and CT scans
There was good dosimetric correlation between these two models as
TA B L E 1 Comparison of TPS and MC organ doses in 10 male NWTS patient-matched CT scans and UF/NCI phantoms
Mean Left kidney Gy
Mean Heart Gy % Heart ≥5 Gy (cc) Mean thyroid Gy 
TA B L E 2 Comparison of TPS and MC organ doses in 10 female NWTS patient-matched CT scans and UF/NCI phantoms
Mean left kidney Gy Mean heart Gy % heart ≥5 Gy (cc) Mean thyroid Gy Tables 1 and 2 show the TPS and MC doses for 10 male and 10 female NWTS patient-matched phantoms and CT scans (rows in Tables 1 and   2 ; aim 2; Figures 1 and 2 
Comparison of organ dosimetry using TPS and MC dosimetry in both patient-matched phantoms and CT scans
respectively. Although the dose for infield organs was similar when using the TPS and MC methods, the doses for near-field and out-offield organs were consistently higher for the MC compared with the TPS dosimetry approach for the majority of dose calculations performed (90%-100%). On average, the MC dose to distant organs such as testes and thyroid gland was larger than that calculated by the TPS by 31.6% (6.8%-59.6%) and 18.25% (0.07%-70.1%), respectively.
However, the absolute dose difference between MC and TPS for testes and thyroid was small (<1 Gy).
DISCUSSION
The seminal NWTS publications from the NWTS LES were for five late effects targeted for data collection from patients (second malignant neoplasms, congestive heart failure, restrictive pulmonary disease, stage renal disease, and adverse pregnancy outcomes). [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] All these reports have consistently implicated higher RT doses, larger RT fields, and doxorubicin as important causative factors for these late effects. However, as described earlier, these studies only considered RT fields and prescribed RT doses without organ dosimetry.
Although modern RT treatments have the capability of providing accurate 3D organ dosimetry, many of the late effects discussed above will require decades of follow-up before any dose-volume correlations can be made. PENTEC (Pediatric Normal Tissue Effects in the Clinic) is a collaborative effort that is currently analyzing past published literature on 3D organ-RT tolerance in children. 32 The main limitation of PENTEC is that the majority of past publications did not provide meaningful 3D dosimetry correlation with late effects. This retrospective dosimetry study will make available 3D organ dosimetry that can be correlated with these NWTS late effects after decades of follow-up. This knowledge will in turn help the current generation of children receive safer RT treatments that may result in a lower incidence of these late effects using modern technology such as Intensity Modulated Radiation Therapy (IMRT) or protons. The NWTS LES data linking congestive heart failure and lung RT has led to the development of a cardiac sparing IMRT protocol that will be adopted in the next generation of Children's Oncology Group (COG) renal tumor protocols. 33 This phantom dosimetry study will also provide physicians, parents, and survivors evidence that can be used to develop more robust follow-up guidelines aimed at risk reduction and mitigation of the impact of treatment-induced late toxicity in childhood cancer survivors.
Accurate dose estimation for infield and out-of-field organs is crucial for evaluating dose-response relationship for both tumor and organs at risk. Although the modern RT TPS is fairly accurate for estimating doses both infield and near-field locations, it is not accurate for out-of-field dose calculations. [11] [12] [13] [14] [15] [16] Howell et al showed that commercial RT TPS (Eclipse) underestimated out-of-field doses by an average of 40% compared with water phantom measurements, and this error was greater (up to 55%) at distances >11 cm from edge of RT fields. 15 Others have also reported that MC dose calculation algorithm measures out-of-field doses accurately. [12] [13] [14] [15] [16] The main dose contributors for out-of-field doses include machine head leakage, scatter through machine components, and internal tissue scatter which are not fully accounted for in TPS calculations. The XVMC MC code used in this report was validated with water phantom measurements out to 30 cm beyond the field edge. 21 In this report, extensive benchmarking of the XVMC dosimetry method was performed by comparing against ion chamber measurements in a water phantom for different field sizes and depths. Errors in the in-plane dose profiles are generally smaller than 25%, except at 20 cm beyond the field edge where they can be as large as 50%. This accuracy is acceptable because the dose received by tissues at these distances is typically quite small (<1% of prescribed dose).
In this report, we have demonstrated the feasibility and accuracy of retrospective dosimetry using this UF/NCI phantom model by demonstrating the lack of any statistical difference between 3D organ doses (both TPS and MC) between 20 NWTS patient-matched phantoms and CT scans. Further, we have also shown that while the infield doses were similar between TPS and MC dosimetry approaches, the out-of-field target organ doses were consistently higher with MC dosimetry compared with standard TPS measurements in these two models. This UF/NCI phantom model would be superior to other older phantom models used by late effects studies such as the Childhood Cancer Survivor Study (CCSS). 34 The older phantom models use dose measurements that are limited to points in a water or anthropomorphic phantom, which may differ according to the size of the patient. On the other hand, the image-based 3D dosimetry approach as used in this study uses height-and weight-matched phantoms and can provide dose at every voxel element in the body. Although CT scans represent the gold standard for modern RT dosimetry, for the conduct of retrospective dosimetry in large-scale epidemiology studies, patient-matched phantoms have the advantage over patientmatched CT scans in that they come with all organs precontoured, thus avoiding the labor-intensive step of organ segmentation in a large number of CT scans. We propose to use this NCI phantom MC dosimetry model as part of an NIH-funded R01 grant to perform retrospective dosimetry on nearly 5000 NWTS patients to study the correlation between 3D organ doses and specific late effects such as congestive heart failure, restrictive pulmonary disease, second malignant neoplasms, end-stage renal disease, infertility, and adverse pregnancy outcomes.
CONCLUSIONS
This pilot study has demonstrated that the patient-matched UF/NCI phantom together with MC dosimetry is an accurate model for performing retrospective 3D dosimetry. This model is a valuable tool for performing retrospective dosimetry in large-scale epidemiology studies such as the NWTS and will permit a more accurate correlation compared with existing methods between 3D organ RT doses and late toxicities observed in childhood cancer survivors. This information will in turn guide the safer delivery of modern RT treatments and also help
